about
The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's diseaseNonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation.Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion.Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrierExpression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptideOatp1a4 and an L-thyroxine-sensitive transporter mediate the mouse blood-brain barrier transport of amyloid-β peptide.Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide.Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticlesFormulations based on alpha cyclodextrin and soybean oil: an approach to modulate the oral release of lipophilic drugsDirect evidence of abca1-mediated efflux of cholesterol at the mouse blood–brain barrierComparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model
P50
Q34267888-0BBCC105-258E-484F-B903-F9E95998D773Q34348184-517AC461-C07F-40B2-986B-2B2FC3EB410FQ35045144-7F3FCB83-FC45-46E7-B259-D40C1FA9D24BQ37119776-E616BAD8-9236-4810-A3A2-1AB7D38CE1B6Q38295848-5DF28F7F-E2A4-4E0F-A1B0-2B80DB789928Q42448451-7295F0EB-5865-41D4-8F40-C1726A99755EQ42484273-02C80F3C-22FD-42A6-B89A-29D90F87B9D5Q42657132-E1CFB09F-4FA8-4017-941B-D8594851972AQ43755296-3FDAB6FD-63E3-46A0-8EFB-3CFCB11F304EQ44570082-663F5A09-A9D1-4DBB-99F6-4A11640A77BDQ44883138-2870A9EA-8AC6-40A0-A97D-02A5CA2B4FF8Q46619495-038000B9-F6FB-4E39-AE93-84ACEE23D21EQ46821666-AC1E0F14-796A-421B-BDFA-2EC2E510AFF6Q47898570-B9F76615-CB6C-419A-AF8B-5083AAB8F9ECQ48202764-F6C1BFFF-B507-4789-A771-F30DDB0CCD77Q58592219-19738681-CFAA-4E76-A0B8-E3AAF1967909Q63433390-9B779343-CC62-4EF1-AEBA-B05292177A38Q63433393-F5896253-C0CB-48E4-827C-8341BBEA204EQ73966081-7B337DCA-5605-4E3F-8CB4-53D2115ACE06
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fanchon Bourasset
@ast
Fanchon Bourasset
@en
Fanchon Bourasset
@es
Fanchon Bourasset
@nl
Fanchon Bourasset
@sl
type
label
Fanchon Bourasset
@ast
Fanchon Bourasset
@en
Fanchon Bourasset
@es
Fanchon Bourasset
@nl
Fanchon Bourasset
@sl
prefLabel
Fanchon Bourasset
@ast
Fanchon Bourasset
@en
Fanchon Bourasset
@es
Fanchon Bourasset
@nl
Fanchon Bourasset
@sl
P1053
A-1870-2017
P106
P21
P31
P3829
P496
0000-0002-1409-8323
P569
2000-01-01T00:00:00Z